英和和英

別の表記

• dideoxycytidine, ddC, DDC

語源

From [Term?] +‎ -citabine (“cytarabine または azacytidine derivative”).

(This etymology is missing または incomplete. Please add to it, または discuss it at the 語源 scriptorium.)

発音

• (Received 発音) IPA^(key): /zalˈsɪt.ə.biːn/
• (General American) IPA^(key): /zælˈsaɪ.təˌbin/, /zælˈsɪt.əˌbin/

名詞

zalcitabine (countable かつ uncountable, 複数形 zalcitabines)

1. (pharmacology) A drug C₉H₁₃N₃O₃ which inhibits the replication of HIV and is formerly used in the treatment of AIDS, especially in combination with zidovudine. It is a synthetic analog of a pyrimidine nucleoside, acting as a reverse transcriptase inhibitor.
   • 1997 July 4, B. Autran et al., “Positive Effects of Combined Antiretroviral Therapy on CD4 T Cell Homeostasis and Function in Advanced HIV Disease”, in Science‎^[1], volume 277, number 5322, DOI:10.1126/science.277.5322.112, pages 112-116:

     Patients received 600 mg/day of ritonavir (Abbott Laboratories) for 14 days, after which were added 600 mg/day of zidovudine (Retrovir, Glaxo-Wellcome) and 6 mg/day of zalcitabine (Hivid, Roche) with treatment maintenance for 12 months.